Get Involved

CRASH-3: Tranexamic Acid for the Treatment of Significant Traumatic Brain Injury

An International, Randomised, Double Blind, Placebo Controlled Trial.

Why is this study important?

Worldwide, over 10 million people are killed or hospitalised because of traumatic brain injury each year. Previous studies examining the use of tranexamic acid in surgical and trauma patients have found that it reduces trauma bleeding. Preliminary work suggests this may also be the case in patients with traumatic brain injury and that tranexamic acid may also reduce the chance of death in this group of patients.

What is the aim of this study?

The aim of CRASH-3 trial is to establish whether early administration of tranexamic acid reduces the rates of death, disability and vascular occlusive events in adult patients with admitted to hospital with a traumatic brain injury.

Trusts currently recruiting:

South Tees NHS Trust

County Durham and Darlington Foundation Trust

For further information about this study please contact/follow link:  http://www.crash.lshtm.ac.uk/

Recruitment to this study is due to end on:  31/12/2016

 

Clinical Trials in Injuries and Emergencies

Select a trial from the list below to find out more about what it’s all about and how you can get involved in helping others.

Haemorrhage Alleviation with Tranexamic Acid [HALT-IT]:

The HALT-IT trial will determine the effect of early administration of tranexamic acid on mortality, morbidity (re-bleeding, non-fatal vascular events), blood transfusion, surgical intervention and health status in patients with acute gastrointestinal bleeding

CRASH-3: Tranexamic Acid for the Treatment of Significant Traumatic Brain Injury

The aim of CRASH-3 trial is to establish whether early administration of tranexamic acid reduces the rates of death, disability and vascular occlusive events in adult patients with admitted to hospital with a traumatic brain injury.

WOLLF:

This study looks at the effectiveness of Negative pressure wound therapy (NPWT) with standard dressings for the prevention of infection in patients presenting to hospital with an open fractures of the lower limb.

Patient Perceptions of Multiple Rib fracture rehabilitation:

This study aims to explore the patient perspective of the current issues surrounding recovery and rehabilitation after traumatic multiple rib fractures.

WHiTE Cohort

The aim of this study is to evaluate the use of PROMs in the context of the National Hip Fracture Audit

WHIST: Wound Healing in Surgery for Trauma. A Randomised Controlled trial of standard wound management versus negative pressure wound therapy in the treatment of adult patients having surgical incisions for major trauma to the lower limb.

The aim of the pragmatic RCT is to compare standard dressings with negative wound therapy for treatment of surgical incisions associated with major trauma of the lower limb.

WHiTE4: A randomised controlled trial of the sliding hip screw versus X-Bolt dynamic plating system for the fixation of trochanteric fractures of the hip.

To investigating the patients’ quality of life after X-Bolt (XB) Dynamic Plating System compared with the Sliding Hip Screw (SHS) in the treatment of trochanteric fracture of the hip.

UK FROST: Multi-centre randomised controlled trial with economic evaluation and nested qualitative study comparing early structured physiotherapy versus manipulation under anaesthesia versus arthroscopic capsular release for patients referred to secondary care with a frozen shoulder (Adhesive Capsulitis)

UK FROST is a multi-centre randomised controlled trial with economic evaluation and nested qualitative study comparing early structured physiotherapy versus manipulation under anesthesia versus arthroscopic capsular release for patients referred to secondary care with a frozen shoulder

GEKO: Neuromuscular electrostimulation (NMES) device, pilot feasibility study looking at time to surgery study in patients requiring ankle fixation following fracture, comparison to matched retrospective controls.

The aim of the study is to show that recruiting, and performing study assessments in ankle fracture patients requiring ORIF attending James Cook University Hospital is feasible, and to obtain data to support the powering of a larger study to demonstrate the effectiveness of the GEKO device at reducing length of stay in hospital for this population of patients.


Latest news from PPI

View all